Helen Mostafavi
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release.
Journal: Science signaling
Published: April 25, 2023
A booster regime of liposome-delivered live-attenuated CHIKV vaccine RNA genome protects against chikungunya virus disease in mice.
Journal: Vaccine
Published: March 09, 2023
Anti-inflammatory actions of Pentosan polysulfate sodium in a mouse model of influenza virus A/PR8/34-induced pulmonary inflammation.
Journal: Frontiers in immunology
Published: August 29, 2022
N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.
Journal: Journal of virology
Published: August 24, 2022
Interleukin-17 Contributes to Chikungunya Virus-Induced Disease.
Journal: mBio
Published: March 07, 2022
Interleukin-17 contributes to Ross River virus-induced arthritis and myositis.
Journal: PLoS pathogens
Published: May 28, 2021
Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose.
Journal: Frontiers in immunology
Published: September 09, 2019
Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease.
Journal: Viruses
Published: February 28, 2019
Chikungunya Arthritis: Implications of Acute and Chronic Inflammation Mechanisms on Disease Management.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 03, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026